Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...

Ozempic, the globally sought-after semaglutide injection that has dominated conversations around diabetes care and weight loss, has finally entered the Indian market. With it, an immediate surge of ...

Indian pharma majors Sun Pharma, Dr Reddy’s, Glenmark, and Zydus Lifesciences on Saturday announced the launch of their generic versions of semaglutide injections, used for diabetes and weight ...

(MENAFN- IANS) New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug's patent expired, offering lower‐cost options ...

As semaglutide’s patent expires in India, over 50 pharma brands including Sun Pharma, Dr Reddy’s and Cipla are racing to ...

Lupin will gain semi-exclusive co-marketing rights for Zydus’ semaglutide injection in India under Semanext and Livarise, while Zydus retains its brands Semaglyn, Mashema and Alterme. Managing ...

Sun Pharma will launch generic semaglutide injection under the brand name, Noveltreat. Ganorkar added, "Noveltreat meets global quality standards and is supported by robust Indian clinical evidence on ...

Zydus Lifesciences on Saturday announced the launch of Semaglutide Injection in India under the brand names SEMAGLYN™, MASHEMA™ and ALTERME™, following patent expiry.

Cipla collaboration brings a second brand of tirzepatide, Yurpeak, to India, aiming to widen patient access for diabetes and ...

Hetero, a leading global pharmaceutical company, on Friday announced the export launch of its generic semaglutide injection portfolio to expand access to treatments for type 2 diabetes and obesity ...

By Rishika Sadam HYDERABAD, India, April 3 (Reuters) - Soon-to-be brides and grooms seeking shortcuts to shed pounds before ...